Cancer survivors in Switzerland: a rapidly growing population to care for

BMC Cancer

Christian Herrmann⁵  Thomas Cerny³  Anita Savidan²  Penelope Vounatsou⁵  Isabelle Konzelmann⁶  Christine Bouchardy⁴  Harald Frick¹  Silvia Ess² 

[1] Cancer Registry Graubünden-Glarus, Chur, Switzerland

[2] Cancer Registry St. Gallen-Appenzell, Cancer League Ostschweiz, St Gallen, Switzerland

[3] Medical Oncology-Hematology Department, Kantonsspital St. Gallen, St. Gallen, Switzerland

[4] Geneva Cancer Registry, Geneva Faculty of medicine, Geneva, Switzerland

[5] University of Basel, Basel, Switzerland

[6] Valais Cancer Registry, Sion, Switzerland

关键词: Switzerland;    Projections;    Time trends;    Complete prevalence;    Survivorship care;    Survivorship;    Cancer survivors;   

Others  :  1079703
DOI  :  10.1186/1471-2407-13-287

 received in 2013-02-18, accepted in 2013-06-10,  发布年份 2013

【 摘 要 】

Background

Cancer survivors are a heterogeneous group with complex health problems. Data concerning its total number and growing dynamics for Switzerland are scarce and outdated.

Methods

Population and mortality data were retrieved from the Swiss Federal Statistical Office (FSO). Incidence and relative survival for invasive cancers were computed using data from the cancer registries Geneva (1970–2009), St. Gallen - Appenzell (1980–2010), Grisons & Glarus (1989–2010), and Valais (1989–2010). We estimated prevalence for 1990–2010 using the Prevalence, Incidence Approach MODel (PIAMOD) method. We calculated trends in prevalence estimates by Joinpoint analysis. Projections were extrapolated using the above models and based on time trends of the period 2007–2010.

Results

The estimated number of cancer survivors increased from 139′717 in 1990 (2.08% of the population) to 289′797 persons in 2010 (3.70%). The growth rate shows an exponential shape and was 3.3% per year in the period 2008 to 2010. Almost half of the survivors have a history of breast, prostate or colorectal cancer. Among cancer survivors, 55% are women but the increases have been more marked in men (p < 0.01, 3.9% annual increase in men vs. 2.7% in women since 2008). By the end of 2020 372′000 cancer survivors are expected to live in Switzerland.

Conclusions

There is a rapidly growing population of cancer survivors in Switzerland whose needs and concerns are largely unknown.

【 授权许可】

   
2013 Herrmann et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P: Cancer incidence in five continents, Volume IX. Lyon: IARC Scientific Publications; 2007.
• [2]Bouchardy C, Lutz J, Kühni C: Cancer in Switzerland: Situation and Development from 1983 up to 2007. Neuchâtel: Federal Statistical Office (FSO), National Institute for Cancer Epidemioloy and Registration (NICER), Swiss Childhood Cancer Registry (SCCR); 2011.
• [3]Ess S, Schwarz-Vucic R: Krebsregister St.Gallen-Appenzell: Jahresbericht 2011. St. Gallen: Krebsregister St. Gallen – Appenzell; 2012.
• [4]Cancer Survivorship: Next Steps for Patients and Their Families. http://www.cancer.net/sites/cancer.net/files/vignette/Cancer_Survivorship.pdf webcite
• [5]National Coalition for Cancer Survivorship. http://www.canceradvocacy.org webcite
• [6]Estimated US Cancer Prevalence Counts: Definitions. http://dccps.nci.nih.gov/OCS/prevalence/definitions.html webcite
• [7]Richardson A, Addington-Hall J, Amir Z, Foster C, Stark D, Armes J, Brearley SG, Hodges L, Hook J, Jarrett N, et al.: Knowledge, ignorance and priorities for research in key areas of cancer survivorship: findings from a scoping review. Br J Cancer 2011, 105(Suppl 1):82-94.
• [8]Hewitt M, Greenfield S, Stovall E: From Cancer Patient to Cancer Survivor: Lost in Transition. Washington: The National Academies Press; 2006.
• [9]The National Cancer Survivorship Initiative Vision. http://www.ncsi.org.uk/wp-content/uploads/NCSI-Vision-Document.pdf webcite
• [10]Improving outcomes: a strategy for cancer. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_123371 webcite
• [11]Mullan F: Seasons of survival: reflections of a physician with cancer. N Engl J Med 1985, 313:270-273.
• [12]Dong C, Hemminki K: Second primary neoplasms in 633,964 cancer patients in Sweden, 1958–1996. Int J Cancer 2001, 93:155-161.
• [13]Bober SL, Recklitis CJ, Campbell EG, Park ER, Kutner JS, Najita JS, Diller L: Caring for cancer survivors: a survey of primary care physicians. Cancer 2009, 115:4409-4418.
• [14]Lutz JM, Francisci S, Mugno E, Usel M, Pompe-Kirn V, Coebergh JW, Bieslka-Lasota M: Cancer prevalence in Central Europe: the EUROPREVAL Study. Ann Oncol 2003, 14:313-322.
• [15]STAT-TAB: Die interaktive Statistikdatenbank. http://www.pxweb.bfs.admin.ch/ webcite
• [16]Verdecchia A, Angelis GD, Capocaccia R: Estimation and projections of cancer prevalence from cancer registry data. Stat Med 2002, 21:3511-3526.
• [17]Kohli R, Bläuer Herrmann A, Babel J: Szenarien zur Bevölkerungsentwicklung der Schweiz - 2010–2060. Neuchâtel: Bundesamt für Statistik (BfS); 2010.
• [18]Dickman PW, Coviello E, Hills M: Estimating and modelling relative survival. Stata J 2009. in press
• [19]Brenner H, Spix C: Combining cohort and period methods for retrospective time trend analyses of long-term cancer patient survival rates. Br J Cancer 2003, 89:1260-1265.
• [20]Berrut S, Junker C: Von Generation zu Generation: Entwicklung der Todesursachen 1970 bis 2004. Neuchâtel: Bundesamt für Statistik (BfS); 2008.
• [21]Kim HJ, Fay MP, Feuer EJ, Midthune DN: Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000, 19:335-351.
• [22]Savidan A, Junker C, Cerny T, Ess S: Premature deaths in Switzerland from 1995–2006: causes and trends. Swiss Med Wkly 2010, 140:w13077.
• [23]NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries, Version 5.3. http://www.ancr.nu webcite
• [24]Maddams J, Utley M, Moller H: Projections of cancer prevalence in the United Kingdom, 2010–2040. Br J Cancer 2012, 107:1195-1202.
• [25]De Angelis R, Grande E, Inghelmann R, Francisci S, Micheli A, Baili P, Meneghini E, Capocaccia R, Verdecchia A: Cancer prevalence estimates in Italy from 1970 to 2010. Tumori 2007, 93:392-397.
• [26]Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. CA Cancer J Clin 2012, 62:10-29.
• [27]Welch HG, Albertsen PC: Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986–2005. J Natl Cancer Inst 2009, 101:1325-1329.
• [28]Bleyer A, Welch HG: Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 2012, 367:1998-2005.
• [29]Bouchardy C, Usel M, Verkooijen HM, Fioretta G, Benhamou S, Neyroud-Caspar I, Schaffar R, Vlastos G, Wespi Y, Schafer P, Rapiti E: Changing pattern of age-specific breast cancer incidence in the Swiss canton of Geneva. Breast Cancer Res Treat 2010, 120:519-523.
• [30]Ess S, Savidan A, Frick H, Rageth C, Vlastos G, Lutolf U, Thurlimann B: Geographic variation in breast cancer care in Switzerland. Cancer Epidemiol 2010, 34:116-121.
• [31]Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, Lin X, Greenfield TK, Litwin MS, Saigal CS, et al.: Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 2008, 358:1250-1261.
• [32]Jansen L, Koch L, Brenner H, Arndt V: Quality of life among long-term (>/=5 years) colorectal cancer survivors–systematic review. Eur J Cancer 2010, 46:2879-2888.
• [33]Hewitt M, Rowland JH, Yancik R: Cancer survivors in the United States: age, health, and disability. J Gerontol A Biol Sci Med Sci 2003, 58:82-91.
• [34]Elliott J, Fallows A, Staetsky L, Smith PW, Foster CL, Maher EJ, Corner J: The health and well-being of cancer survivors in the UK: findings from a population-based survey. Br J Cancer 2011, 105(Suppl 1):S11-S20.
• [35]Parry C, Kent EE, Mariotto AB, Alfano CM, Rowland JH: Cancer survivors: a booming population. Cancer Epidemiol Biomarkers Prev 2011, 20:1996-2005.